Matthias Will, MD
Chief Development Officer (CDO) @ Autolus Therapeutics
About
I am passionate to bringing effective therapies to cancer patients. As a physician trained in oncology as well as skilled in commercialization strategy, I am uniquely qualified to change the paradigm of cancer care and enable physicians and payors to provide the best medical care possible. In the past 10 years, my teams have launched 5 new products, guided the expansion of the oncology portfolio and partnered with several of the Top 20 pharma companies. I thrive in tackling complex challenges within a fast moving environment where I can build and nurture successful and accountable teams.
United States
San Francisco Bay Area
Biotechnology
Regulatory Submissions, Clinical Strategy, Translational Medicine, Approval Process, Oncology, Pharmaceutical Industry, Medical Devices, Clinical Research, Product Launch, Healthcare, Cardiology, Clinical Development, Global Marketing, Clinical Trials, Health Economics, Diabetes, German, French, Market Access, Pharmaceutical Sales
Experience
Chief Development Officer (CDO)
Autolus Therapeutics
San Francisco Bay Area
Leading a world class team of development experts to bring new cell therapies to patients suffering from life threatening diseases.
Chief Medical Officer
Dren Bio
San Francisco Bay Area
Building and leading the development organization to develop the first-in-class CD94 antibody in T-cell lymphomas and auto-immune diseases and the myeloid cell engaging bispecifics for vairous tumor types.
VP Clinical Development
CRISPR Therapeutics
San Francisco Bay Area
Led the clinical development of the first in class allogeneic CRISPR gene edited CAR T cell program targeting CD70 in T cell lymphomas and RCC as well as the partnered gene engineered NK cell program.
VP Clinical Development
CytomX Therapeutics
South San Francisco, California
Led a team of MDs and clinical scientist to file 4 INDS and develop drugs to mid-stage clinical development, stand-alone as well as pharma partnered programs
Senior Director Clinical Development
CytomX Therapeutics
South San Francisco
Preparing our first-in-human study for CytomX proprietary Probody platform, proteins such as antibodies cleaved by proteases only active in the tumor microenvironment.
Medical Director Oncology
Gilead Sciences
Foster City, CA
Supported the approval of the first Pi3K inhibitor and development of additional indications.
Head Medical Affairs and Marketing MDx
Novartis
San Diego, CA
Late-stage development and product launch of several targeted therapies (Pi3K, PTEN, FGF, FLT-3) with their respective companion diagnostics in Oncology
Head Marketing & Market Access Companion Diagnostics
Novartis
Developed and implemented strategies for access to targeted therapies (TKIs) in conjunction with companion diagnostics for Oncology products
Director
Novartis
Basel Area, Switzerland
Led strategic project for the Novartis Group and Novartis Pharma
Business manager
GE HealthCare
•Orchestrated project delivery to strategic clients in Central Europe and the Middle East in support of large public-private partnership engagements investment and service agreements. •Proved integral to a variety of projects including capital and performance agreements with cancer care hospital systems located in Europe and the Middle East
Engagement Manager
McKinsey & Company
Offices: COL, LON, NEJ Selected studies include: •Defined a new Market Access Strategy to counter austerity measures such as “jumbo group pricing” for a Top 10 global pharma player in EU5 markets. •Integrated a new anti-coagulation franchise for global pharma players. •Aligned sales forces in Poland, Hungary, and Czech Republic for a top generic player as a component of post-merger integration
Residency in Hematology & Oncology
University of Tübingen
Tübingen Area, Germany
Education
Harvard Medical School
Medicine
Medizinische Hochschule Hannover
Medicine
Université de Rennes I
Medicine
The University of Bonn
Medicine
Matthias Will, MD's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.